Hubify Ltd Frames 89% EBITDA Lift Around AI First Managed Intelligence Pivot [VIDEO]
Hubify's FY26 investor presentation reveals an 89% EBITDA lift to $0.66m, a 315% surge in net operating cash, and a strategic pivot from Managed Service Provider to AI-first Managed Intelligence Provider — here's what investors need to know.
Key Takeaways
- Hubify's EBITDA surged 89% to $0.66m in FY26, completing a full turnaround from a $4.36m loss in FY24, while net operating cash grew 315% year-on-year to $1.41m.
- Recurring revenue reached 90% of total revenue in FY26, up from 87% in the prior two years, with the company holding $3.79m in cash and carrying zero bank debt at period end.
- A co-branded MSA with Optus is already generating enterprise engagements with named clients including CBUS, HammondCare, Transdev, GE HealthCare and BOC.
- Hubify's AI-first pivot involves taking equity stakes and options in AI solution partners — including HubLab, GADALI, LABRYNTH and TechData — alongside earning advisory and implementation fees from enterprise clients navigating AI adoption.
- Management identified accretive acquisitions and high-margin revenue growth as the core FY27 priorities, supported by a pipeline described as building well with opportunities expected to close in early FY27.
![Aland Equity Group Locks in Rights to Sell 56 Lots Targeting $75K Net Per Lot [VIDEO]](https://media.stockwirex.com/land-for-sale-sign.jpg)
![X2M Connect Ltd Lands First $250M+ AI Data Centre Contract [VIDEO]](https://media.stockwirex.com/Data-Center-Interior-9.jpg)
![Austin Engineering Ltd Locks in $43.9M HSBC Refinancing to 2029 [VIDEO]](https://media.stockwirex.com/lobby-with-signage.jpg)
Breaking ASX Alerts Direct to Your Inbox
Join +20,000 subscribers receiving alerts.
Join thousands of investors who rely on StockWire X for timely, accurate market intelligence.
- Breaking ASX announcements delivered within minutes
- Alerts delivered with expert analysis
- Optional text alert for subscribers
- No spam policy, unsubscribe any time
About the Publisher
StockWire X delivers fast, reliable, and actionable insights into significant developments across global markets, with coverage spanning technology, biotechnology, healthcare, financials, and emerging industries. Our mission is to provide clear, data-driven content that empowers investors to identify opportunities and make informed decisions ahead of the market.
Our network spans key financial and investment hubs worldwide, ensuring subscribers receive timely updates on market-moving announcements, news, macroeconomic trends, and corporate developments.
Use of Technology
We harness advanced technologies to enhance the speed, accuracy, and relevance of our reporting.
While technology accelerates our workflow, every piece of content is selected, validated, and published by human professionals, in accordance with best practices for accuracy, transparency, and investor value. This hybrid approach ensures speed without compromising editorial integrity.
Feedback and Accuracy
We are committed to accuracy and fairness in our reporting. If you believe any information we have published is inaccurate, incomplete, or misleading, please contact us at admin@stockwirex.com so we can review and address the matter promptly.
Disclaimer
StockWire X provides readers with access to market news, educational content, and commentary from financial services professionals, industry experts, and companies (“Contributors”).
StockWire X Pty Ltd (CAR No. 001 322 642) is a Corporate Authorised Representative of ShareX Pty Ltd (AFSL No. 519872), regulated by the Australian Securities and Investments Commission (ASIC). StockWire X is authorised to provide general financial product advice in relation to basic deposit products, securities, and managed investment schemes.
Any advice or information published by StockWire X is general in nature only and has been prepared without taking into account your personal objectives, financial situation, or needs. Before acting on any information, you should consider whether it is appropriate for your circumstances and seek independent, licensed financial advice. You should also obtain and read any relevant Product Disclosure Statement (PDS) or other offer document before making an investment decision.
StockWire X makes no guarantee as to the accuracy, completeness, or timeliness of the information provided, and accepts no responsibility for any loss arising from reliance on it. All content is published in good faith for informational purposes only.
Disclosure
StockWire X may have commercial relationships with some contributors or companies mentioned in our content. Any such relationships will be disclosed where relevant.
If you believe any information we have published is inaccurate, incomplete, or misleading, please contact us at admin@stockwirex.com so we can review and address the matter promptly.
Disclaimer